1.Preclinical Research
1.1 Role of human heterogeneous nuclear ribonucleoprotein C1/C2 in dengue virus replication
1.2 Quantitative Analysis of Some Phenolic Compounds in Ayurved Siriraj Wattana (AVS073) Using HPTLC
1.Clinical Research
1.1 Dyspareunia and Sexual Dysfunction after Vaginal Delivery in Thai PrimiparousWomen with Episiotomy
1.2 HLA class I supertypeassociations with clinical outcome of secondary dengue virus infections in ethnic Thais
2.Preclinical Research
2.1 Testosterone reduces AGTR1 expression to prevent β-cell and islet apoptosis from glucotoxicity
Professor Dr. Kovit Pattanapanyasat, Head of Center of Excellence of Flow cytometry, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University was rewarded 21st Science and Technology award for 400,000 Baht by Thailand Toray Science Foundation on 9th March 2015. Professor Dr. Kovit Pattanapanyasat is over 25 years expertise in flow cytometry application for immunology, Thalassemia and infectious diseases such as Malaria, Dengue virus and HIV/AIDS. Moreover, he developed CD4 Lymphocyte measurement to be high quality, standardize and low cost, for examples, BioLeucotag and Biobeads. Inevitably, WHO and Thailand MOPH U.S. CDC Collaboration have an honorary Professor Dr. Kovit invitation to be a committee to assess the efficiency of flow cytometry and he pushed External Quality Assurance/EQA in Thailand for CD4 measurement.
1.Clinical Research
Effects of Power and Time on Ablation Size Produced by Radiofrequency Ablation: In vitro Study in Fresh Human Placenta
1. Multidisciplinary Research
1.1 Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer
1.2 Orientia tsutsugamushi, agent of scrub typhus, displays a single metapopulation with maintenance of ancestral haplotypes throughout continental South East Asia
2. Preclinical Research
2.1 Microparticlesin Dengue Infection Provide a Novel Biomarker to Predict Severe Clinical Outcomes
On 25th November, 2014, Associate Professor Dr. Chatchawan Srisawat, Chairman of Biochemistry Department and members of Cancer Nanomedicine welcomed Professor Juri Gelovani.
Professor Juri gave 2 hours special lecture “PET Tracers Development in Oncology” for doctor and researchers at the meeting room 901, 9th Floor, SiMR building. After that he visited laboratory centers on 5th and 7th Floor and also the accomodation on 11th Floor of SiMR building.
On November 13,2014, Department of Immunology, Research Division, International Relations Division, Faculty of Medicine Siriraj Hospital, and Erasmus MC together hosted a meeting under the topic of “Updates on Immunology and Endocrinology” to Promote research collaboration and Sharing experience between both institutes at SiMR building, 12nd floor. The meeting was seasoned by several reputed speakers from Erasmus MC led by Professor Dr. Martin van Hagen, Head of Department of Clinical Immunology and Professor Dr. Aart-Jan van der Lely, Head of Department of Clinical Endocrinology, Erasmus MC.
The Award of Excellence for Clinical Research
1.Assoc. Prof. Vip Viprakasit Department of Pediatrics
Title : Mutations in Krüppel like factor 1 cause transfusion dependent hemolytic anemia and persistence of embryonic globin gene expression
2.Assoc. Prof. Jeerunda Santiprabhob Department of Pediatrics
Title :Outcomes of group based treatment program with parental involvement for the management of childhood and adolescent obesity.
The Award of Excellence for Biomedical Research
3.Lecturer Dr.Siwanon JirawatnotaiDepartment Pharmacology
Title:The cyclin D1 CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.
4.Lecturer Dr.Juthathip Mongkolsapaya Office of Research and Development
Title : A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
On November 29, 2013, Dr. Boonpote Siridechadilok, researcher of Medical Biotechnology Laboratory BIOTEC who is in charge of Dengue division, department of research and development revealed in the conference press about viral development on dengue vaccine. This project was granted 100,000 USD for 18 months of research support by Grand Challenges Canada.
Dengue Hemorrhagic Fever (DHF) is a mosquito-borne tropical disease that is among the most prevalent health challenges worldwide. Although vaccine development has proven effective to certain degrees, there are 400 million DHF infected people each year, with another 3 billion people prone to this infection.
According to Dr. Boonpote, “Understanding the comprehensive details of the dengue virus and its regulation will be the most crucial essence in developing a vaccine for DHF protection.”
In the present time, most of the vaccine developers focus on the live attenuated vaccine approach screening/creation—where viral mutation will be screened in the culture, or engineered.
According to Dr. Boonpote, “The original viral engineering has less genetic diversity than developed laboratory viral engineering. The developed laboratory viral engineering broadens the genetic diversity up to 10,000 times than that of the original. Moreover, this technique can analyze with high efficiency to investigate the mutation.”
Grand Challenges Canada funding is supported by the Canadian government for projects with high impacts on health sciences, technology, social and business innovations in developing countries. This funding objective is to encourage direct practices and applications of research for the well-being of the general population. In addition, there are 3 more awarded researchers namely: Dr. Surakameth Mahasirimongkol, TB/HIV Research Foundation (THRF), Assistant Professor Dr. Thanat Chookajorn, and Dr.Yoel Lubell, Mahidol University.
On October 16, 2013, Lecturer Dr. Siwanon Jirawatnotai was awarded the 2013 TRF-CHE-Scopus Young Researcher Awards in Health Sciences by Professor Pavich Tongroach, Assistant Minister for Education, at The Regent Cha Am Beach Resort, Huahin, Phetchaburi.
The award was granted by the concords of Thailand Research Fund (TRF), Office of Higher Education and Elsevier publisher (journal database of Scopus). This award recognizes new and intermediate researcher, with a project(s) that is pending upon receiving the TRF funding application or a remarkable project(s) within a span of 2 years.
